Security key
803607100
Sarepta Therapeutics, Inc. - COMMON STOCK (SRPT)
CUSIP: 803607100
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 82,768,888
- Total 13F value
- $1,414,059,003
- Share change
- -4,084,004
- Put/Call ratio
- 74%
- SEC-reported price per share
- $17.10
- Number of holders
- 354
- Value change
- -$616,173,124
- Number of buys
- 218
- Number of sells
- 210
- Shares outstanding
- 106,144,083
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
354
Top holders
10
SRPT full security history
Ownership snapshot
Full 13F holder table
Sarepta Therapeutics, Inc. SEC filings
Sarepta Therapeutics, Inc. company facts
Sarepta Therapeutics, Inc. 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of SRPT - Sarepta Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital International Inv...
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
13D/G
Lead comparable stake: 0.5%
13D/G row: Capital International Investors
Showing 1-6 of 15 holder rows.
Quick read
Capital International Investors leads the comparable SEC ownership view at 0.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital International Investors's linked filing trail.
Comparable ownership
Top 5
Capital International Investors
0.5%
BlackRock, Inc.
9.3%
VANGUARD GROUP INC
8.5%
STATE STREET CORP
3.8%
Janus Henderson Group Ltd.
3.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital International Investors |
13F
13D/G
Company
|
0.5%
from 13D/G
|
$578,292,911
9,060,772 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
9.3%
|
$632,256,316
9,906,868 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
8.5%
|
$576,461,361
9,032,613 shares
|
— | 31 Mar 2025 |
| STATE STREET CORP |
13F
Company
|
3.8%
|
$259,649,883
4,068,472 shares
|
— | 31 Mar 2025 |
| Janus Henderson Group Ltd. |
13F
Company
|
3.2%
|
$236,884,912
3,364,845 shares
|
— | 31 Mar 2025 |
| Avoro Capital Advisors LLC |
13F
Company
|
2.5%
|
$170,707,970
2,674,835 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
354
Shares
82,768,888
Rows available
354
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
419
Q2 2025 holders
354
Holder diff
-65
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|